Advanced 3D imaging of the cornea to improve diagnosis and treatment
In vivo high-definition 3D corneal imaging
['FUNDING_SBIR_2'] · LIGHTOPTECH CORPORATION · NIH-10783792
This study is testing a new, gentle imaging technology that helps doctors see the cornea in 3D, which could lead to better diagnosis and treatment for corneal diseases that can cause blindness, especially in places where eye care is limited.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LIGHTOPTECH CORPORATION (nih funded) |
| Locations | 1 site (WEST HENRIETTA, UNITED STATES) |
| Trial ID | NIH-10783792 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a high-definition, non-invasive imaging technology called Gabor-domain optical coherence microscopy (GDOCM) to visualize the cornea in three dimensions. By providing a detailed view of the corneal structure, this technology aims to enhance the diagnosis and monitoring of corneal diseases, which are a leading cause of blindness, particularly in developing countries. The approach allows for simultaneous measurement of corneal thickness and cell density, potentially leading to better treatment outcomes. Patients will benefit from improved diagnostic accuracy and personalized treatment plans based on detailed imaging data.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from corneal diseases, particularly those in developing countries where access to advanced diagnostic tools is limited.
Not a fit: Patients with corneal conditions that are not amenable to imaging or those who do not reside in areas where this technology will be implemented may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the diagnosis and management of corneal diseases, reducing the risk of blindness for many patients.
How similar studies have performed: Other research has shown promising results with advanced imaging techniques in ophthalmology, suggesting that this approach could lead to significant advancements in corneal disease management.
Where this research is happening
WEST HENRIETTA, UNITED STATES
- LIGHTOPTECH CORPORATION — WEST HENRIETTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CANAVESI, CRISTINA — LIGHTOPTECH CORPORATION
- Study coordinator: CANAVESI, CRISTINA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Corneal Disorder, cornea disorder, Corneal Diseases